Can You Sell Peptides With Stripe? What the Policy Says

The short answer

No. Stripe publishes a restricted businesses list, and research peptides sit inside its pharmaceutical-adjacent categories: products positioned as pseudo pharmaceuticals or nutraceuticals, and substances sold for human use without the approvals that use would require. The restriction is categorical. It does not depend on your chargeback rate, your labeling, or how clean your store is, which is the pattern across mainstream processors, covered in why processors drop peptide companies.

What Stripe's policy says

Stripe's list exists because its banking and card network partners set the boundaries of what Stripe may process. Restricted categories are the ones where those partners see regulatory ambiguity or elevated dispute risk, and research peptides carry both: the products are sold for research use only, while the surrounding market openly discusses human use. An underwriter does not resolve that ambiguity in your favor. The list also reaches connected platforms, so storefront builders and marketplaces that settle through Stripe inherit the same boundary, which is why the restriction follows you across tools that look unrelated, including Shopify Payments.

How enforcement lands

The peptide seller's experience of Stripe is rarely a rejection at signup. Onboarding is automated and quick, so the account opens, checkout works, and revenue flows. Classification happens later: monitoring reads the catalog, the descriptor, the dispute pattern, or a manual review lands, and the account is closed with funds held while reversals clear. The store loses its rail and a slice of its working capital on the same day. What those holds do to cash flow is covered in reserves, holds, and freezes, and a card-network termination can also leave a flag that follows your next application, explained in the MATCH list.

After Stripe

If the closure just happened, start with the recovery playbook. For the rebuild, there are two honest paths. A high-risk merchant account keeps you on cards, at the cost of underwriting, category pricing, and reserves; the option comparison weighs it properly. Or remove the processor from the flow entirely: Peer Pay is checkout software, not a processor, so there is no underwriting file to maintain and no account to lose. Customers pay you directly from payment apps they already use, a cryptographic proof verifies the payment, and settlement lands as USDC in a wallet you control. The full flow is in how proof-verified checkout works.

FAQ

Does Stripe allow peptide sales?

No. Research peptides fall inside the pharmaceutical-adjacent categories on Stripe's published restricted businesses list, so peptide stores are not an eligible business type. Accounts that process peptide volume anyway are routinely closed when review catches up.

My Stripe account works today. Does that mean my peptide store was approved?

No. Stripe onboarding is fast and largely automated, and review continues after the account is live. An account that opens and processes normally can still be closed later when monitoring classifies the catalog, and by then there is revenue in the balance.

What happens to my money if Stripe closes my peptide store's account?

Stripe's terms let it hold funds after a closure while disputes and reversals clear, a window that commonly runs into months. Orders in flight and the held balance both become working-capital problems, which is why the first week after a closure matters.

What do peptide sellers use instead of Stripe?

Either a high-risk merchant account that underwrites the category, or checkout software with no processor in the middle. With Peer Pay, customers pay you directly from payment apps they already use, a cryptographic proof verifies the payment, and you receive USDC in a self-custodial wallet.